Homebiotech

biotech

biotech

Base to Base biotech podcast 82: Restoring blood flow to the heart and tackling HHT

Jim Cornall - October 30, 2026

biotech

Early results from “encouraging” pancreatic cancer study

Jim Cornall - October 29, 2026

biotech

Familiar Therapeutics launches to close gap between human and veterinary medicine

Jim Cornall - October 29, 2026

biotech

Scientists create white blood cell with memory of how to fight off winter flu bugs

Jim Cornall - October 29, 2026

AI

Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance

Jim Cornall - July 18, 2025

biotech

Arcus Biosciences receives Orphan Drug Designation for pancreatic cancer treatment

Jim Cornall - July 17, 2025

biotech

IGI and AbbVie announce exclusive global licensing agreement for trispecific antibody

Jim Cornall - July 17, 2025

biotech

Angelman syndrome results published

Jim Cornall - July 17, 2025

biotech

Champions Oncology launches radiopharmaceutical services platform

Jim Cornall - July 16, 2025

biotech

Partnership created scale up cell-based mRNA design and manufacturing platform

Jim Cornall - July 16, 2025

biotech

New drug target for treating cancer and viral infections

Jim Cornall - July 16, 2025

biotech

Consortium looks to deliver fully automated robotics CGT manufacturing platform

Jim Cornall - July 15, 2025

1...979899...109 Page 98 of 109

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 82: Restoring blood flow to the heart and tackling HHT

Jim Cornall - October 30, 2026 0

This week, we have a conversation with Philip Brainin, CEO of Isomab, about restoring blood flow to the heart, and with RougeTx CEO Andrew...

Early results from “encouraging” pancreatic cancer study

biotech Jim Cornall - October 29, 2026 0

Familiar Therapeutics launches to close gap between human and veterinary medicine

biotech Jim Cornall - October 29, 2026 0

Scientists create white blood cell with memory of how to fight off winter flu bugs

biotech Jim Cornall - October 29, 2026 0

Topline results from metastatic breast cancer phase 3 trial

biotech Jim Cornall - October 28, 2026 0